Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cellebrite DI Ltd. - Ordinary Shares (NQ:CLBT)

18.10 -0.10 (-0.55%)
Streaming Delayed Price Updated: 3:44 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cellebrite DI Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
10 AI Stocks Worth Buying Right Now ↗
Building an artificial intelligence (AI) portfolio means looking beyond the obvious megacap names. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Cellebrite Completes Acquisition of Corellium, Extending the Industry’s Most Advanced AI-Powered Digital Investigation Platform
The addition of Corellium’s leading virtualization technology to the Cellebrite platform delivers unmatched capabilities that transcend digital forensics, investigations, analytics and intelligence 
From Cellebrite DI Ltd
Via GlobeNewswire
News headline image
Should Investors Buy Shares of Cellebrite Alongside Portolan Capital as They Double Down on the Stock? ↗
Portolan opened a position in Cellebrite early in 2024 and doubled down on the stock in the third quarter, making the company its tenth-largest holding. 
Via The Motley Fool
News headline image
Earnings Scheduled For November 12, 2025 ↗
 
Via Benzinga
Super League, Terawulf, Cellebrite Dominate Stocktwits Retail Chatter Among Tech Stocks: Find Out Why ↗
Via Stocktwits
News headline image
These Fast-Rising Tech Stocks Are Surging in Growth Scores This Week ↗
 
Via Benzinga
News headline image
This Fund Sold $9 Million of Ligand Stock After an 84% Rally — What Investors Should Know ↗
A high-conviction fund just trimmed one of its biggest winners—here’s what long-term investors should make of the move. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why One Small-Cap Fund Bought $11 Million in Cellebrite Stock Last Quarter ↗
A specialist small-cap fund just doubled down on a digital-intelligence company that's underperforming the broader market. 
Via The Motley Fool
News headline image
This Fund Cut $7.3 Million of Atlas Energy Stock as the Company Suspends Its Dividend to Help Fuel Growth ↗
One fund just took a step back from a struggling energy name—right as the company suspended its dividend to fund future growth. 
Via The Motley Fool
Topics Economy Regulatory Compliance
News headline image
Why Cellebrite Stock Is Skyrocketing Today ↗
Cellebrite just served up some great news for investors with its latest quarterly report. 
Via The Motley Fool
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
12 Information Technology Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Cellebrite (CLBT) Q3 2025 Earnings Call Transcript ↗
Cellebrite (CLBT) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Which stocks are gapping on Thursday? ↗
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
News headline image
Spectrum Brands Posts Upbeat Q3 Earnings, Joins Ondas Holdings, Firefly Aerospace, Cellebrite DI And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
News headline image
AutoZone To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Thursday ↗
 
Via Benzinga
News headline image
12 Information Technology Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Cisco Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Wednesday's after hours session: top gainers and losers ↗
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
News headline image
12 Information Technology Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Cellebrite Announces Third-Quarter 2025 Results
From Cellebrite DI Ltd
Via GlobeNewswire
News headline image
Cellebrite Appoints Holly Windham as General Counsel and Chief Compliance Officer
Appointment Builds on the Momentum Behind Cellebrite’s Preeminent Digital Investigation Portfolio and Market-Leading Investigative Solutions to Accelerate Justice 
From Cellebrite DI Ltd
Via GlobeNewswire
News headline image
Actor, Host, Artist and Anti-Human Trafficking Advocate Terry Crews to Headline Cellebrite C2C User Summit 2026
From Cellebrite DI Ltd
Via GlobeNewswire
News headline image
Cellebrite to Report Third-Quarter 2025 Financial Results on November 12, 2025
From Cellebrite DI Ltd
Via GlobeNewswire
News headline image
Cellebrite Expands Market Reach with Innovations in Agentic AI, Cloud and Device Virtualization for the Company’s Autumn 2025 Release
From Cellebrite DI Ltd
Via GlobeNewswire
News headline image
Applied Materials To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday ↗
 
Via Benzinga
News headline image
Cellebrite Reports 21 Percent ARR Growth ↗
Via The Motley Fool
News headline image
Cellebrite Begins Its Next Chapter ↗
Cellebrite experienced solid growth in Q2 2025, exceeding expectations for sales and earnings. Signs of a rebound are encouraging. 
Via The Motley Fool
News headline image
Cellebrite DI Ltd (NASDAQ:CLBT) Posts Mixed Q2 2025 Earnings Amid Leadership Changes and Strategic Moves ↗
Cellebrite reports mixed Q2 2025 results: revenue slightly misses estimates at $113.3M, while EPS beats at $0.12. New CEO appointed amid leadership changes and strategic acquisitions. Stock dips... 
Via Chartmill
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.